Akili reports first quarter 2024 financial results and provides business update

Boston--(business wire)--akili, inc. (nasdaq: akli), a leading digital medicine company, today reported its financial results for the quarter ended march 31, 2024 and provided an update on business progress. as announced in late april 2024, the company's board of directors has initiated a process that is currently ongoing to evaluate potential strategic alternatives to maximize shareholder value. “we are working expeditiously with our board of directors and our external advisors and look forwar.
AKLI Ratings Summary
AKLI Quant Ranking